Conference Reports for NATAP

19th International Workshop on Clinical Pharmacology of Antiviral Therapy May 22, 2018 Baltimore, USA | Baltimore Marriott Inner Harbor Back

Tweet

Rifabutin (RBT) Decreases Cabotegravir (CAB) Exposure Following Oral Co-administration       Reported by Jules Levin 19th International Workshop on Clinical Pharmacology of Antiviral Therapy 2018 Baltimore, MD, USA 22-24 May 2018   S Ford,1 Y Lou,2 N Lewis,3 R D'Amico,4 W Spreen,4 P Patel4   1GlaxoSmithKline, Research Triangle Park, NC; 2Parexel International, Research Triangle Park, NC; 3GlaxoSmithKline, UP, PA; 4ViiV Healthcare, Research Triangle Park, NC